Literature DB >> 20156960

Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial.

Elise D Cook1, Kathryn B Arnold, John A Hermos, Worta McCaskill-Stevens, Sarah Moody-Thomas, Jeffrey L Probstfield, Sandra J Hamilton, Russell D Campbell, Karen B Anderson, Lori M Minasian.   

Abstract

BACKGROUND: African American accrual to prevention trials at rates representative of the disease burden experienced by this population requires additional resources and focused efforts.
PURPOSE: To describe the rationale, context, and criteria for selection of sites that received Minority Recruitment Enhancement Grants (MREGs) to increase African American recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). To determine if African American accrual was higher among the 15 MREG sites when compared with similar nonawarded sites.
METHODS: Changes in African American accrual at sites that received MREGs are compared with changes in a group of 15, frequency-matched, nonawarded sites using a quasi-experimental, post hoc analysis. Successful and unsuccessful recruitment strategies reported by the MREG sites are described.
RESULTS: The increased number of African American participants accrued per month at MREG sites post-funding was higher than the change at comparison sites by a factor of 3.38 (p = 0.004, 95% CI: 1.51-7.57). An estimated 602 additional African American participants were recruited at MREG sites due to MREG funding, contributing to the overall 14.9% African American recruitment. Successful recruitment strategies most reported by MREG sites included increasing staff, transportation resources, recruiting through the media, mailings, and prostate cancer screening clinics during off-hours. LIMITATIONS: Comparison sites were chosen retrospectively, not by randomization. Although comparison sites were selected to be similar to MREG sites with regard to potential confounding factors, it is possible that unknown factors could have biased results. Cost-effective analyses were not conducted.
CONCLUSIONS: MREG sites increased African American accrual in the post-funding period more than comparison sites, indicating MREG funding enhanced the sites' abilities to accrue African American participants. Targeted grants early in the accrual period may be a useful multi-site intervention to increase African American accrual for a prevention study where adequate African American representation is essential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156960      PMCID: PMC3956599          DOI: 10.1177/1740774509357227

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  21 in total

1.  Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community.

Authors:  M N Fouad; E Partridge; B L Green; C Kohler; T Wynn; S Nagy; S Churchill
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

2.  Recruitment in NHLBI population-based studies and randomized clinical trials: data analysis and survey results.

Authors:  J L Probstfield; J T Wittes; D B Hunninghake
Journal:  Control Clin Trials       Date:  1987-12

3.  PCPT update: enrollment mounts, but minority participation lags.

Authors:  T Reynolds
Journal:  J Natl Cancer Inst       Date:  1994-10-19       Impact factor: 13.506

4.  Minority recruitment in the prostate cancer prevention trial.

Authors:  C M Moinpour; J O Atkinson; S M Thomas; S M Underwood; C Harvey; J Parzuchowski; L C Lovato; A M Ryan; M S Hill; E Deantoni; E R Gritz; I M Thompson; C A Coltman
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

5.  Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Authors:  Elise D Cook; Sarah Moody-Thomas; Karen B Anderson; Russell Campbell; Sandra J Hamilton; Joseph M Harrington; Scott M Lippman; Lori M Minasian; Electra D Paskett; Stephen Craine; Kathryn B Arnold; Jeffrey L Probstfield
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

6.  African-American attitudes regarding cancer clinical trials and research studies: results from focus group methodology.

Authors:  B L Green; E E Partridge; M N Fouad; C Kohler; E F Crayton; L Alexander
Journal:  Ethn Dis       Date:  2000       Impact factor: 1.847

7.  Enrollment in clinical trials according to patients race: experience from the VA Cooperative Studies Program (1975-2000).

Authors:  Eugene Z Oddone; Maren K Olsen; Jennifer Hoff Lindquist; Melinda Orr; Ronnie Horner; Domenic Reda; Philip Lavori; Gary Johnson; Joseph Collins; John R Feussner
Journal:  Control Clin Trials       Date:  2004-08

8.  Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans.

Authors:  S Millon-Underwood; E Sanders; M Davis
Journal:  Cancer Nurs       Date:  1993-02       Impact factor: 2.592

Review 9.  Accrual to cancer clinical trials: directions from the research literature.

Authors:  C C Gotay
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

10.  Recruiting Black/African American men for research on prostate cancer prevention.

Authors:  V Diane Woods; Susanne B Montgomery; R Patti Herring
Journal:  Cancer       Date:  2004-03-01       Impact factor: 6.860

View more
  10 in total

1.  Evaluating a community-partnered cancer clinical trials pilot intervention with African American communities.

Authors:  Melissa A Green; Margo Michaels; Natasha Blakeney; Adebowale A Odulana; Malika Roman Isler; Alan Richmond; Debra G Long; William S Robinson; Yhenneko J Taylor; Giselle Corbie-Smith
Journal:  J Cancer Educ       Date:  2015-03       Impact factor: 2.037

2.  The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.

Authors:  Joseph M Unger; Elise Cook; Eric Tai; Archie Bleyer
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

3.  Retention of black and white participants in the selenium and vitamin E cancer prevention trial (SWOG-coordinated intergroup study S0000).

Authors:  Kathryn B Arnold; John A Hermos; Karen B Anderson; Lori Minasian; Catherine M Tangen; Jeffrey F Probstfield; Elise D Cook
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-09-21       Impact factor: 4.254

4.  The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Authors:  Andrea M Denicoff; Worta McCaskill-Stevens; Stephen S Grubbs; Suanna S Bruinooge; Robert L Comis; Peggy Devine; David M Dilts; Michelle E Duff; Jean G Ford; Steven Joffe; Lidia Schapira; Kevin P Weinfurt; Margo Michaels; Derek Raghavan; Ellen S Richmond; Robin Zon; Terrance L Albrecht; Michael A Bookman; Afshin Dowlati; Rebecca A Enos; Mona N Fouad; Marjorie Good; William J Hicks; Patrick J Loehrer; Alan P Lyss; Steven N Wolff; Debra M Wujcik; Neal J Meropol
Journal:  J Oncol Pract       Date:  2013-10-15       Impact factor: 3.840

Review 5.  Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.

Authors:  Moon S Chen; Primo N Lara; Julie H T Dang; Debora A Paterniti; Karen Kelly
Journal:  Cancer       Date:  2014-04-01       Impact factor: 6.860

Review 6.  Applying a Conceptual Framework to Maximize the Participation of Diverse Populations in Cancer Clinical Trials.

Authors:  A Napoles; E Cook; T Ginossar; K D Knight; M E Ford
Journal:  Adv Cancer Res       Date:  2016-10-05       Impact factor: 5.767

Review 7.  Strategies to improve recruitment to randomised trials.

Authors:  Shaun Treweek; Marie Pitkethly; Jonathan Cook; Cynthia Fraser; Elizabeth Mitchell; Frank Sullivan; Catherine Jackson; Tyna K Taskila; Heidi Gardner
Journal:  Cochrane Database Syst Rev       Date:  2018-02-22

8.  Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China.

Authors:  Shiyu Jiang; Peng Liu; Sheng Yang; Jianliang Yang; Dawei Wu; Hong Fang; Yan Qin; Shengyu Zhou; Jianping Xu; Yongkun Sun; Hongnan Mo; Lin Gui; Puyuan Xing; Bo Lan; Bo Zhang; Le Tang; Yan Sun; Yuankai Shi
Journal:  BMJ Open       Date:  2019-06-01       Impact factor: 2.692

9.  Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review.

Authors:  Karen Bracken; Lisa Askie; Anthony C Keech; Wendy Hague; Gary Wittert
Journal:  BMJ Open       Date:  2019-04-03       Impact factor: 2.692

10.  The Impact of an Educational Video on Clinical Trial Enrollment and Knowledge in Ethnic Minorities: A Randomized Control Trial.

Authors:  Jeannine S Skinner; Alecia M Fair; Alexis S Holman; Alaina P Boyer; Consuelo H Wilkins
Journal:  Front Public Health       Date:  2019-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.